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Aims The role of high-intensity exercise and other emerging risk factors in lone atrial fibrillation (Ln-AF) epidemiology is still
under debate. The aim of this study was to analyse the contribution of each of the emerging risk factors and the impact
of physical activity dose in patients with Ln-AF.
Methods
and results
Patients with Ln-AF and age- and sex-matched healthy controls were included in a 2:1 prospective case–control study.
We obtained clinical and anthropometric data transthoracic echocardiography, lifetime physical activity questionnaire,
24-h ambulatory blood pressure monitoring, Berlin questionnaire score, and, in patients at high risk for obstructive
sleep apnoea (OSA) syndrome, a polysomnography. A total of 115 cases and 57 controls were enrolled. Conditional
logistic regression analysis associated height [odds ratio (OR) 1.06 [1.01–1.11]], waist circumference (OR 1.06 [1.02–
1.11]), OSA (OR 5.04 [1.44–17.45]), and 2000 or more hours of cumulative high-intensity endurance training to a high-
er AF risk. Our data indicated a U-shaped association between the extent of high-intensity training and AF risk. The risk
of AF increased with an accumulated lifetime endurance sport activity ≥2000 h compared with sedentary individuals
(OR 3.88 [1.55–9.73]). Nevertheless, a history of ,2000 h of high-intensity training protected against AF when com-
pared with sedentary individuals (OR 0.38 [0.12–0.98]).
Conclusion A history of ≥2000 h of vigorous endurance training, tall stature, abdominal obesity, and OSA are frequently encoun-
tered as risk factors in patients with Ln-AF. Fewer than 2000 total hours of high-intensity endurance training associates
with reduced Ln-AF risk.
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Introduction
Atrial fibrillation (AF) is the most common sustained arrhythmia in
clinical practice, substantially increasing the risk of stroke, hospital-
ization, and mortality. Well-defined risk factors for AF include
advanced age, hypertension, structural heart disease, diabetes
mellitus, and thyroid disease. However, AF may develop in patients
without these traditional aetiologic factors, known as lone AF
(Ln-AF).1
In recent years, emerging Ln-AF risk factors such as high-intensity
endurance sport,2 obesity,3 and obstructive sleep apnoea4 (OSA)
syndrome have been identified. However, the role of physical activ-
ity in the risk of developing AF remains under debate. Moreover, in
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the absence of traditional aetiologic factors for AF, a complete
work-up is frequently not performed and little is known about the
impact of these emerging risk factors.5
The aims of our study were to explore the contribution of phys-
ical activity to Ln-AF, focusing on the dose–response relationship;
to analyse whether a complete work-up in patients with Ln-AF
may uncover previously undiagnosed risk factors; and to study the
prevalence of these risk factors and their contribution to AF risk.
Methods
We designed a prospective, observational, cross-sectional study.
Patients with Ln-AF and age- (+3 years) and sex-matched healthy
controls were recruited. Written informed consent was obtained
from all participants. The protocol was approved by the Ethics Commit-
tee of our institution.
An extended description of Methods is provided in the Supplemen-
tary material online.
Patient population
The study population (cases) consisted of consecutive patients with
Ln-AF at their first visit at our centre. Lone atrial fibrillation was defined
as AF in the absence of any cardiopulmonary identifiable cause of the
arrhythmia, hypertension, or diabetes. Control subjects were recruited
among healthy hospital visitors, excluding relatives of AF patients. All in-
dividuals underwent a comprehensive clinical history and echocardiog-
raphy to rule out exclusion criteria. Exclusion criteria were .60 years
of age, any cardiovascular disease, hypertension, diabetes mellitus,
chronic obstructive pulmonary disease and liver, thyroid, infectious or
inflammatory diseases, as well as AF secondary to illicit-drug or alcohol
abuse.
Anthropometric indexes
Weight, height, waist and hip circumference, and body mass index (BMI)
were assessed in all participants. Abdominal obesity was defined accord-
ing to international guidelines: .102 cm (men) or .88 cm (women).
Blood sample analytics
Cytokines mediating systemic inflammation [interleukin 1 (IL-1),
interleukin 6 (IL-6), and C-reactive protein (CRP)], neurohormones
[atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and
aldosterone], and proteins involved in extracellular matrix turnover
[matrix metalloproteinase 2 (MMP-2), matrix metalloproteinase
9 (MMP-9) and tissue inhibitor of metalloproteinase 1 (TIMP-1)] were
measured in blood samples.
Echocardiographic parameters
All participants underwent a comprehensive transthoracic echocardiog-
raphy study. Left ventricular (LV) dimensions, ejection fraction, diastolic
function, and left atrial (LA) antero-posterior diameter were measured.
Regular sport practice
A modified version of the validated Minnesota Leisure-Time Physical
Activity Questionnaire was administered by a research nurse. This ques-
tionnaire estimates lifetime-accumulated physical activity and identifies
those individuals at an increased risk of exercise-induced AF.2 For
each activity, the following variables were recorded: age of starting
and ending, months of practice per year, days practised per week and
hours per day (see Supplementary material online, S1). Participants
were asked to classify the intensity of each physical activity into four cat-
egories: sedentary (intensity 1), activities requiring no physical effort
with minimal walking; light (intensity 2), activities requiring minimal
physical effort such as slow walking, with no increase in heart rate and
no perspiration; moderate (intensity 3), activities that are not exhausting
but slightly increase heart rate and may cause some light perspiration;
and high intensity (intensity 4), vigorous activities resulting in intense
sweating and deep-breathing.
Berlin questionnaire
The Berlin questionnaire identifies patients at high risk for OSA. It com-
prises three items: snoring, wake-time sleepiness or tiredness, and the
presence of either obesity or hypertension (see Supplementary material
online, S2). When available, the patient’s bed-partner was asked to con-
firm the accuracy of responses on snoring. Scores from the first and
second categories were positive if responses indicated frequent symp-
toms; the third category was positive if BMI . 30 kg/m2 (hypertensive
patients were excluded per protocol). Patients were considered at high
risk for OSA if scored positive in two or three categories.6
Polysomnography
Participants with a high-risk Berlin questionnaire score underwent over-
night laboratory-based video polysomnography. The apnoea–hypop-
nea index (AHI) was calculated as the average number of apnoea’s
and hypopneas per hour; OSA was diagnosed when AHI was ≥5.6
Ambulatory blood pressure monitoring
Ambulatory blood pressure monitoring (ABPM) was performed using a
Spacelabs 90207/90217 monitor (Richmond, WA, USA). According to
current guidelines, average BP . 130/80 mmHg on 24-h ABPM was
considered as masked hypertension.
Statistical analysis
Continuous data are expressed as mean+ SD. Categorical variables are
expressed as number (percentage). Blood-test parameters did not fol-
low normal distribution; their square-root-transformation was used.
We used receiver-operating characteristic (ROC) and positive likeli-
hood ratio to evaluate the optimal cut-off point for accumulated high-
intensity training and stature.
Conditional logistic regression and backward-stepwise selection algo-
rithms were used to determine the variables associated with Ln-AF.
Variables to be included in the multivariate model were selected using
a P-value of ,0.10 in univariate analysis. Local likelihood regression was
used to establish the association between Ln-AF and total hours of high-
intensity training.
A two-tailed P-value of ,0.05 was considered statistically significant.
The analyses were performed using R v3.0.1 (the R project for Statistical
Computing; Vienna, Austria).
What’s new?
† Emerging risk factors long-term high-intensity endurance
training, obstructive sleep apnoea, obesity, and tall stature
are found in over 75% of patients with lone AF.
† The relationship between physical activity and Ln-AF inci-
dence follows a U-shaped curve, with individuals having exer-
cised for limited periods of time being at the lowest risk.
† The lifetime-accumulated hours of vigorous training is the
most powerful predictor of exercise-induced AF.
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Sample size was estimated on the basis of previous observations.2
We estimated 114 AF patients and 57 healthy individuals in a 2:1 design
would provide an 80% power to detect a significant (P, 0.05) estimate
of an AF-risk odds ratio (OR= 1) between the two study groups if
prevalence of intense physical activity was 50% in the Ln-AF group
and 33% in the control group.
Results
A total of 115 cases and 57 controls were included (2:1 match, ex-
cept for 1 control that was matched to 3 cases). Most participants
(87%) were male, aged 46+ 10 years (Table 1). Atrial fibrillation
characteristics are summarized in Supplementary material online,
Table S1. Atrial fibrillation was paroxysmal in 60% of cases and
had vagal triggers in 46%. In 14% of cases, AF was present at the
inclusion visit.
Anthropometric indices
Anthropometric data are shown in Table 1. Patients with Ln-AF
were taller (177 vs. 174 cm, OR 1.06 [1.01–1.11]). There were
no differences in BMI between groups, but waist circumference
was significantly larger in cases than in controls (95 vs. 91 cm, OR
1.06 [1.02–1.11]). The proportion of participants with abdominal
obesity was higher in cases than in controls (27 vs. 14%, OR 3.03
[1.09–8.39]).
Blood sample analyses
Enhanced systemic inflammation was observed in patients
with Ln-AF, evidenced by increased CRP and IL-1 (Table 2).
ANP and BNP were also increased in Ln-AF patients, but no
changes were found in collagen-turnover parameters. Sensitivity
analyses excluding patients with ongoing AF at the inclusion visit
did not affect these results (see Supplementary material online,
Table S2).
Berlin questionnaire and obstructive sleep
apnoea diagnosis
High-risk Berlin questionnaire scores were more common in cases
than controls (35 vs. 10%, OR 5.03[1.88–13.43]). Definite OSA was
diagnosed in 22% of cases and 5% of controls (OR 5.01 [1.44–
17.45]) (Table 1).
Echocardiographic parameters
Echocardiographic parameters are shown in Table 3 and Supple-
mentary material online, Table S3. Both crude- and indexed-
LA diameter were larger in patients with Ln-AF; there were
no differences between cases and controls in LV-wall thickness
or diastolic function. Left ventricular ejection fraction was
marginally lower in patients with Ln-AF (59 vs. 63%, OR 0.92
[0.86–0.98]).
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Table 1 Baseline clinical characteristics
Variable Lone AF patients (n 5 115) Control group (n5 57) OR (95% CI) P-value
Age (years) 46+10 46+10
Male (%) 100 (87%) 50 (86%)
Height (cm) 177+8 174+8 1.06 (1.01–1.11) 0.03
Weight (kg) 83+13 78+12 1.04 (1.01–1.07) 0.02
BMI (kg/m2) 26+3 26+3 1.07 (0.97–1.19) 0.18
Waist circumference (cm) 95+11 91+10 1.06 (1.02–1.10) ,0.01
Hip circumference (cm) 100+9 101+8 1.00 (0.96–1.03) 0.83
High-risk score for OSA 39 (34%) 6 (10%) 5.03 (1.88–13.43) ,0.001
Definite OSA 23 (22%) 3 (5%) 5.01 (1.44–17.45) 0.01
BMI, body mass index; OSA, obstructive sleep apnoea.
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Table 2 Analytic measurements
Variable Lone AF patients (n 5 115) Control group (n 5 57) OR (95% CI) P-value
IL-1 (ng/mL) 0.12 (0.29) 0 (0.08) 2.69 (1.05–6.98) 0.045
IL-6 (pg/mL) 1.2 (1.5) 0.8 (0.7) 1.73 (0.92–3.22) 0.086
CRP (mg/dL) 0.08 (0.24) 0.05 (0.09) 4.77 (1.11–20.59) 0.036
Aldosterone (ng/dL) 6.4 (5.7) 6.65 (4.4) 1.14 (0.74–1.74) 0.55
ANP (fmol/mL) 51 (50) 29 (20) 1.42 (1.15–1.75) 0.001
BNP (pg/mL) 22.5 (53.4) 8.7 (13.3) 1.45 (1.19–1.77) ,0.001
MMP-2 (ng/mL) 290.6 (65.5) 283.5 (66.3) 1.0 (0.8–1.26) 0.97
MMP-9 (ng/mL) 103.6 (104.1) 88.8 (69.1) 1.07 (0.96–1.19) 0.21
TIMP-1 (ng/mL) 76.5 (23.4) 78.5 (14.4) 0.85 (0.63–1.17) 0.32
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Sport activity
The lifetime-accumulated hours of exercise, the average number of
hours of vigorous exercise per year, and the age at beginning of vig-
orous training were significantly associated with AF in the univariate
analysis (Table 4). Only lifetime total hours of exercise remained
significant in the multivariate analysis. The lifetime-accumulated
hours of high-intensity endurance training was significantly higher
in cases than in controls (4686 vs. 985 h, OR 1.02 [1.01–1.03]
per 100-h increase). A ROC analysis showed that an accumulation
of 2000 h was the best cut-off predicting AF presence. This cut-off
point served to split participants into three clinically meaningful
groups: (i) sedentary (no high-intensity exercise); (ii) ,2000 h of
lifetime-accumulated, high-intensity endurance training, comprising
individuals who had performed limited vigorous activity; and
(iii) ≥2000 h of lifetime-accumulated, high-intensity endurance
training, comprising heavy-performer individuals (Table 5). In com-
parison to sedentary individuals, AF risk increased with ≥2000 h
lifetime-accumulated high-intensity training (OR 3.88 [1.55–9.73]).
Conversely, a history of ,2000 h of high-intensity training signifi-
cantly protected against AF (OR 0.38 [0.12–0.98]). When consid-
ered as a continuous variable, the relationship of lifetime-accumulated
high-intensity training to AF risk followed a U-shaped dose–response
curve (Figure 1).
Regression analyses suggested significant cardiac remodelling
with increasing lifetime-exercise hours (see Supplementary material
online, Table S4). Competitive athletes at the regional or national
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Table 3 Echocardiographic assessment of lone AF patients and controls
Variable Lone AF patients (n 5 115) Control group (n 5 57) OR (95% CI) P-value
LA-AP diameter (mm) 39+6 36+4 1.15 (1.06–1.24) ,0.001
LVEDD (mm) 51+6 51+4 1.02 (0.95–1.09) 0.57
LVESD (mm) 33+6 32+4 1.06 (0.98–1.13) 0.11
IVW (mm) 10+2 10+1 0.96 (0.74–1.26) 0.79
PW (mm) 10+2 10+1 0.88 (0.67–1.16) 0.37
LVEF (%) 59+8 63+5 0.92 (0.86–0.98) ,0.01
Diastolic pattern: impaired relaxation (%) 7 6 1.47 (0.37–5.89) 0.72
LA-AP, left atrial antero-posterior diameter; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; IVW, interventricular wall; PW, posterior
wall; LVEF, left ventricular ejection fraction.
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Table 4 Exercise-related parameters associated with AF
Univariate analysis Multivariate analysis
OR (95% CI) P-value Stand. b OR (95% CI)
Age at beginning vigorous exercise (per year) 0.96 (0.93–0.99) 0.01 20.504
Lifetime-accumulated vigorous exercise (per 100 h) 1.02 (1.0069–1.032) 0.003 1.22 1.041 (1.013–1.07)
Hours of vigorous exercise per year (per 10 h) 1.023 (1.005–1.042) 0.015 0.588
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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Table 5 Risk of AF associated with the presence of emerging risk factors
Variables Univariate Multivariate
OR CI (95%) P-value OR CI (95%) P-value
Abdominal obesity 3.03 1.09–8.39 0.03
Height (.179 cm) 3.31 1.52–7.19 ,0.01 2.11 0.93–4.83 0.06
Obstructive sleep apnoea 5.01 1.44–17.45 0.01 4.27 1.16–15.65 0.02
Sport activity
Sedentary 1 1
High-intensity exercise,2000 h 0.38 0.12–0.98 0.04 0.48 0.16–1.47 0.19
High-intensity exercise ≥2000 h 3.88 1.55–9.73 ,0.001 2.83 1.18–6.79 0.02
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level were at a higher risk of AF (OR 2.74 [0.88–8.47]), but this
effect was largely blunted after adjusting for total exercise hours
(Table 6). Patients with Ln-AF who had been engaged in intensive
training were predominantly participating in cycling, marathon run-
ning, and diverse team sports (see Supplementary material online,
Table S5). After adjusting for cumulated hours of exercise, endur-
ance sports carried a higher AF risk in comparison to team sports
(OR 5.68 [1.72–18.7]) (Table 6).
Blood pressure
The ABPM revealed that 38% of controls and 34% of cases suffered
masked hypertension (OR 0.78 [0.35–1.72]) (see Supplementary
material online, Table S6). This proportion was maintained after ex-
cluding AF patients treated with beta-blockers or calcium-antagonists
or regular exercisers (not shown). Masked hypertension had no im-
pact on LA size among controls. Nevertheless, LA was enlarged in
Ln-AF patients with masked hypertension in comparison with those
without masked hypertension (see Supplementary material online,
Figure S1).
Overall and cumulative risk
Multivariate analysis showed that prolonged high-intensity endur-
ance training, OSA, and tall stature were independently associated
with Ln-AF (Table 5). Overall, at least one emerging risk factor
was found in 76% of patients with Ln-AF (81 of 107 patients):
43% of patients had performed ≥2000 h of vigorous exercise,
44% were taller than 179 cm, abdominal obesity was present in
27% of them and OSA in 21% of patients. Atrial fibrillation risk
was higher in individuals with more than one of these factors
(Figure 2).
Discussion
To the best of our knowledge, this is the first study exhaustively ana-
lysing the prevalence and contribution of non-traditional emerging
risk factors to AF incidence in a population of unselected patients
with Ln-AF (Table 5). We show that after a comprehensive explor-
ation, a non-traditional aetiologic factor can be identified in most pa-
tients with Ln-AF. Furthermore, we describe for the first time a
U-shaped association between the duration of high-intensity train-
ing and the risk of developing Ln-AF.
Lone atrial fibrillation
The notion of ‘Lone AF’ was first coined to identify young patients
with AF and no evidence of causative heart disease, hypertension, or
diabetes. We focussed our work in the identification of recently de-
scribed ‘emerging’ aetiologic factors in the absence of these well-
known aetiologic factors. Nevertheless, it should be acknowledged
that the ‘lone AF’ concept has been frequently mixed up with ‘idio-
pathic AF’, thus leading to inconsistent definitions and misleading
discussions.1 We show that at least one emerging risk factor can
be identified in most Ln-AF patients, hence disputing the notion
of ‘idiopathic AF’ in our cohort.
Sport activity
We establish a U-shaped dose – response between lifetime-
accumulated high-intensity endurance training and risk of Ln-AF.
Individuals having exercised vigorously for a limited number of
hours were at the lowest risk of AF (Figure 1). Moreover, we
find that the lifetime-accumulated hours of vigorous activity is
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Figure 1 Percentage (95% CI) of participants with lone AF
(cases) according to accumulated high-intensity physical exercise
(local likelihood regression). Of note, proportion is dependent
on cases/control matching in a specific study sample; in our study
(2:1 matching), a percentage of 66% would indicate lack of associ-
ation between exercise and AF.
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Table 6 Risk of AF in specific exercise subgroups
Unadjusted
data
Adjusted for
lifetime-accumulated
exercise
Competitive sport 2.74 (0.88–8.47) 0.88 (0.23–3.43)
Exercise type
Team sports 1 1
Endurance sports 3.4 (1.37–8.4) 5.68 (1.72–18.7)
Other 3.03 (0.9–9.7) 4.59 (0.5–41.1)
8.08 (3.08–25.19)
2.65 (1.12–6.26)
1
1
Two or more risk factors
One risk factor
No risk factors
10
OR (95% CI)
100
Figure 2 Risk of AF in patients according to the presence of risk
factors shown in Table 5 (OR and 95% CI).
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the most powerful predictor for exercise-induced AF, suggesting
that the total accumulated insult to the atria correlates to the ar-
rhythmic substrate.
Physical inactivity is a well-known major cardiovascular risk fac-
tor; in contrast, regular exercise prevents cardiovascular events.
Our study extends previous findings on the health benefits of exer-
cise to patients with Ln-AF: sedentary individuals are at increased
risk of AF when compared with those engaged in regular, time-
limited, training. Conversely, as in the previous studies,2,7 – 10 we
found that AF risk increases with long-term, vigorous, endurance
sport practice (≥2000 h in our cohort).
The upper limit of ‘safe’ endurance training has been elusive.
Elosua et al.2 demonstrated that an accumulated sport practice
of .1500 h was associated with an increased risk of AF. Data
from Drca et al.9 suggested that .5 h/week of vigorous intensity
exercise at 30 years of age increased AF incidence beyond the sixth
decade of life. In our study, a 2000-h threshold better discrimi-
nated individuals at risk for exercise-induced AF. However, the
training/AF-risk dose– response curve is likely continuous and
shows a high inter-individual variability. Undertaking epidemio-
logical studies to identify a threshold for screening purposes in
this setting might be spurious, and clinical decisions should be
individualized.
In this work we show that, in comparison to individuals involved
in collective sports, those undergoing intense endurance training are
at a higher risk of AF. To our knowledge, only one study has found a
higher than expected AF incidence in team sports practitioners,11 in
contrast to a large body of evidence for endurance athletes.7 – 9 A
more sustained haemodynamic overload in endurance athletes like-
ly contributes; however, our study was not designed to address
these differences.
The mechanisms involved in exercise-induced AF are increasingly
being identified.12 In our study, abdominal obesity is more frequent
in sedentary than highly active patients (34 vs. 16%, P ¼ 0.01); we
therefore speculate that regular training protects against AF by re-
ducing abdominal obesity burden.
Our data suggest that regular vigorous exercise should be as-
sessed in patients with an Ln-AF diagnosis. Although experimental12
and clinical8 reports suggest that deconditioning might reverse
exercise-induced AF substrate and prevent recurrences, further
studies are warranted to establish a therapeutic role for training dis-
continuation in exercise-induced AF.
Obesity
Several studies have pointed to obesity as an independent risk factor
for AF. Nevertheless, the definition of obesity is inconsistent across
studies. Body mass index has been extensively used to identify indi-
viduals at risk of AF.3 Other groups have implicated the metabolic
syndrome in the development of AF.13 In the REGARDS study, AF
prevalence was higher in patients with a larger waist circumfer-
ence.13 Zhang et al.14 reported that BMI and waist circumference
predicted AF incidence and suggested the superiority of waist cir-
cumference over BMI. The present study extends these observa-
tions to patients with Ln-AF, and demonstrates that waist
circumference is superior to BMI as an Ln-AF predictor. Therefore,
we propose systematic assessment of waist circumference in the
evaluation of patients with Ln-AF.
Masked hypertension
In the general population, hypertension is the most important risk
factor for AF. For the first time, we have assessed the prevalence
of masked hypertension by mean of ABPM in patients with Ln-AF.
Our data show that one in three Ln-AF patients has abnormally
high blood pressure values. Similarly, a small study by Katritsis
et al.15 revealed that 44% of patients with Ln-AF were diagnosed
with hypertension after a 3-year follow-up, but a control group
was not provided. In our study, masked hypertension was equally
frequent in cases and controls, thus suggesting it has no significant
role in Ln-AF pathology. Nevertheless, masked hypertension was
associated with more dilated atria in patients with Ln-AF. It is likely
that masked hypertension contributes to AF-induced LA dilation,
thereby accelerating AF self-perpetuation mechanisms. The LA of
Ln-AF patients might be more sensitive to haemodynamic stretch.
Further studies are needed to address this issue.
Obstructive sleep apnoea syndrome
In patients with AF, OSA prevalence ranges from 32 to 49%.4,16 Our
data reveal that OSA is present in 22% of Ln-AF patients, conferring
a five-fold increase in AF risk. Patients with structural heart disease
and hypertension were excluded from our Ln-AF cohort, account-
ing for a lower prevalence of OSA in this series in comparison with
previous reports.
Obstructive sleep apnoea increases AF risk through autonomic
imbalance and chronic structural remodelling,17 and thereby in-
creases AF recurrence after electric cardioversion4 and AF-ablation
procedures.16,18 Most studies have proved continuous positive air-
way pressure (CPAP) to be beneficial in preventing AF-relapses,
although conflicting results have also been published.4
A rationale for OSA screening stems from its high prevalence in
Ln-AF patients and the potential benefits of CPAP therapy in terms
of AF prevention. We show that Berlin questionnaire score effi-
ciently identifies a subpopulation of Ln-AF patients at high risk of
OSA who should undergo polysomnography for a definitive OSA
diagnosis. Overall, .65% of patients with a high-risk Berlin ques-
tionnaire score were diagnosed with OSA. This efficient and
easy-to-administer tool should be included systematically in initial
evaluation of Ln-AF patients.
Height
Reports studying an association between stature and AF incidence
are scarce. This association was first suggested by Hanna et al.19
in an epidemiological study including .25 000 patients with heart
failure. They showed a progressive increase in AF risk from lower
to higher stature-quartile. Later studies extended this relationship
to patients with Ln-AF,10 and Rosenberg et al.20 revealed that taller
individuals were at higher risk of incident and prevalent AF in the
general population. The present study confirmed an association be-
tween stature and Ln-AF, independently of other emerging AF risk
factors. Mechanisms mediating this association are largely unknown.
Stature keeps its prognostic significance even after adjusting for LA
diameter.10 A recent study suggested that single nucleotide poly-
morphism rs1046934 mediates the association between stature
and AF risk.21 Further studies are needed to elucidate whether stat-
ure is a risk factor or a risk marker.
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Left atrial enlargement
Left atrial abnormalities, including dilatation, are frequent in Ln-AF
patients.2 Initially, AF risk factors contribute to atrial dilation; recur-
rent AF events promote AF self-perpetuation, partially through LA
dilation.22 Similar to previous studies, our results demonstrate LA
dilatation in patients with Ln-AF. However, its role is uncertain,
and both primary and AF self-perpetuation mechanisms might ac-
count for atrial dilatation in our Ln-AF cohort.
Inflammation
We found an enhanced systemic pro-inflammatory status in patients
with Ln-AF. The persistence of this association in patients with sinus
rhythm, along with well-known pro-inflammatory effects of factors
such as OSA and abdominal obesity, suggests that inflammation
mediates Ln-AF substrate in our patients. However, further studies
are needed to confirm this hypothesis.
Limitations
Some limitations of our study should be acknowledged. First, we es-
timated lifetime-accumulated physical activity through a retrospect-
ive questionnaire, which is subject to inaccuracies. We adapted our
questionnaire from the widely used Minnesota Leisure-Time Ques-
tionnaire, and validated it in a previous work. Parameters such as
maximum VO2 might serve to precisely quantify actual fitness, but
fail to estimate physical activity performed during the whole life. Sec-
ondly, our study was conducted with a rather small sample size, but
was powered enough to address our aims and obtaining significant
positive correlations. Thirdly, although our population had a low
cardiovascular risk (no symptoms, no ECG or echocardiographic re-
gional abnormalities, low predicted risk), we cannot completely ex-
clude coronary disease in all individuals.
Conclusion
Limited high-intensity training protects against Ln-AF. Conversely,
long-lasting high-intensity endurance training, height, abdominal
obesity, and OSA are frequent risk factors for Ln-AF. A diagnosis
of Ln-AF should lead to exhaustive efforts to rule out underlying
emerging risk factors.
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